Confident automakers adding factory workers
Plants in Indiana and other states are slowly expanding as car companies foresee improved sales due to pent-up demand, population growth and an aging vehicle fleet.
Bloomberg News
Articles
BorgWarner sues Cummins over patents on turbochargers
BorgWarner Inc., the world’s biggest maker of automatic-transmission parts for vehicles, filed a lawsuit accusing Cummins Inc. of infringing on three patents for a titanium wheel used in engine turbochargers.
Lilly pulls Xigris off market after sepsis drug fails study
Eli Lilly and Co. said it will pull its Xigris sepsis drug from all markets after the treatment failed to reduce mortality in a study. The withdrawal may cost Lilly $75 million to $95 million in the fourth quarter.
Simon boosts forecast as quarterly results exceed expectations
Indianapolis-based shopping mall giant Simon Property Group Inc. reported funds from operations that beat analyst estimates and raised its full-year forecast as income from rents rose.
Pacer Foster earns reputation as Buffett of basketball
Indiana Pacer Jeff Foster has played in the NBA for 12 years and earned more than $47 million, and he’s done something extraordinary: He’s saved about three-quarters of his take-home pay.
Lilly diabetes drug wins approval for expanded use
Eli Lilly and Co. and Amylin Pharmaceuticals Inc.’s Byetta has received expanded approval for use with the world’s top-selling insulin to treat Type 2 diabetes.
Farm plan may preserve crop subsidies, groups say
A bill backed by Indiana Sen. Richard Lugar would consolidate several subsidy programs into a plan to aid farmers when revenue declines.
Cook Medical gets FDA panel’s backing for stent
The device would be the first drug-coated stent approved in the U.S. to treat peripheral vascular disease in the largest artery of the upper leg.
FDA: Cook Medical’s stent met efficacy, safety goals
Peripheral vascular devices, including stents, angioplasty balloons and synthetic grafts, generated $4.3 billion in global revenue last year and may earn $5.6 billion in 2014.
Cummins needs to hire 7,000 engineers, CEO says
Columbus-based engine maker Cummins Inc. needs to add 7,000 engineers within five years, CEO Theodore Solso said Wednesday.
Lilly CEO says he’s not interested in Pfizer animal unit
Drugmaker Eli Lilly and Co. doesn’t plan to buy Pfizer Inc.’s $3.58 billion animal-health business, CEO John Lechleiter said Wednesday.
Election spending to exceed $6B thanks to Indiana lawyer
Indiana attorney James Bopp Jr. has spent 30 years fighting limits on campaign spending, and next year’s political landscape could be transformed by his labor.
Farm subsidies may face cuts amid record profits
U.S. farmers earning record profits are fighting to maintain agricultural subsidies, a likely target of the congressional supercommittee working to reduce federal spending.
Eli Lilly, Turkish firm in talks to sell drugs in 26 nations
Eli Lilly and Co., the world’s biggest maker of psychiatric drugs, is in talks with Mustafa Nevzat Ilac Sanayii AS to sell the Turkish company’s treatments in 26 countries, said Mustafa Nevzat’s CEO.
WellPoint expands share buyback plan by $5 billion
The insurer said it will use the authorization over several years as market and industry conditions dictate.
NCAA sued by ex-college football players over head injuries
The National College Athletic Association has been sued by two former college football players who claim the organization failed to enforce safety measures to protect them from concussions.
Irsay backtracks on out-for-season statement about Manning
Peyton Manning has an outside chance of returning in December, Indianapolis Colts owner Jim Irsay said on Twitter after local media quoted him saying Monday morning that the injured quarterback would be out for the season.
Non-candidates Christie, Daniels loom over presidential race
Governors Chris Christie of New Jersey and Mitch Daniels of Indiana have ruled themselves out of the 2012 race for the White House. Yet both Republicans are keeping themselves in the public eye.
WellPoint buying private health insurance exchange
The deal helps WellPoint compete for employers with the U.S. state-run marketplaces set to open in 2014 under President Obama’s health-care overhaul.
Debate rages over whether Lilly’s Byetta lifts cancer risk
A German researcher disputed the validity of a study that found Byetta and another diabetes drug increase cancer risk.